Hannah Cabot

Hannah Cabot is a Senior Manager in R&D Strategy at Quotient Therapeutics. Prior to this, Hannah held intern positions in investment teams at Lightrock, Novartis, and Hadean Ventures. Hannah also has experience as a Senior Consultant at Putnam Associates and as an Associate in M&A at Back Bay Life Science Advisors. Hannah holds an MBA from London Business School and a Bachelor of Arts in Biology from the University of Pennsylvania.